CIK 0001000694
- Large accelerated filer
NOVAVAX INC
Sign in to watch- Ticker
- NVAX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 222816046
- Phone
- +1 240-268-2000
- Business address
- 21 FIRSTFIELD RD, GAITHERSBURG, MD
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-09-26 | Trizzino John EVP, CBO and CFO | Exercise or conversion · Restricted Stock Units | −31,900 | 0 | ||
| 2020-09-26 | Trizzino John EVP, CBO and CFO | Exercise or conversion · Restricted Stock Units | −3,538 | 7,076 | ||
| 2020-09-26 | Glenn Gregory M President, R&D | Exercise or conversion | +38,588 | 40,149 | ||
| 2020-09-26 | Glenn Gregory M President, R&D | Shares withheld for taxes | −18,639 | $113.56 | $2.1M | 21,510 |
| 2020-09-26 | Glenn Gregory M President, R&D | Exercise or conversion · Restricted Stock Units | −38,588 | 0 | ||
| 2020-09-26 | Herrmann John A III EVP, Chief Legal Officer | Exercise or conversion | +30,900 | 31,175 | ||
| 2020-09-26 | Herrmann John A III EVP, Chief Legal Officer | Shares withheld for taxes | −14,925 | $113.56 | $1.7M | 16,250 |
| 2020-09-26 | Herrmann John A III EVP, Chief Legal Officer | Exercise or conversion | +3,973 | 20,223 | ||
| 2020-09-26 | Herrmann John A III EVP, Chief Legal Officer | Shares withheld for taxes | −1,919 | $113.56 | $218K | 18,304 |
| 2020-09-26 | Herrmann John A III EVP, Chief Legal Officer | Exercise or conversion · Restricted Stock Units | −30,900 | 0 | ||
| 2020-09-26 | Herrmann John A III EVP, Chief Legal Officer | Exercise or conversion · Restricted Stock Units | −3,973 | 7,946 | ||
| 2020-08-24 | Herrmann John A III EVP, Chief Legal Officer | Grant or award · Stock Option (Right to Buy) | +125,000 | 125,000 | ||
| 2020-08-24 | Trizzino John EVP, CBO and CFO | Grant or award · Stock Option (Right to Buy) | +140,000 | 140,000 | ||
| 2020-08-24 | Glenn Gregory M President, R&D | Grant or award · Stock Option (Right to Buy) | +165,000 | 165,000 | ||
| 2020-08-24 | Erck Stanley C President and CEO | Grant or award · Stock Option (Right to Buy) | +400,000 | 400,000 | ||
| 2020-08-18 | Trizzino John EVP, CBO and CFO | Exercise or conversion | +11,249 | $99.80 | $1.1M | 16,336 |
| 2020-08-18 | Trizzino John EVP, CBO and CFO | Exercise or conversion | +5,855 | $27.00 | $158K | 22,191 |
| 2020-08-18 | Trizzino John EVP, CBO and CFO | Exercise or conversion | +1,952 | $27.00 | $53K | 24,143 |
| 2020-08-18 | Trizzino John EVP, CBO and CFO | Exercise or conversion | +13,322 | $27.60 | $368K | 37,465 |
| 2020-08-18 | Trizzino John EVP, CBO and CFO | Exercise or conversion | +10,410 | $46.00 | $479K | 47,875 |
Page 81 of 87 · 1,734 trades